https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-81999-01-09 00:00:002019-02-15 09:18:00[Hyperthermia in combination with chemotherapy in gynecological cancers]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Urol Int 1999;63(3):151-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Urol Int 1999;63(3):151-91999-01-01 00:00:001999-01-01 00:00:00Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-71999-01-01 00:00:001999-01-01 00:00:00Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Gene Ther. 1999 Jan;6(1):63-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Gene Ther. 1999 Jan;6(1):63-731999-01-01 00:00:002020-06-23 09:46:30Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Cancer Chemother. Pharmacol. 1999;43(5):409-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Cancer Chemother. Pharmacol. 1999;43(5):409-141999-01-01 00:00:002019-02-15 09:17:59A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
